Improving detection and care for chronic kidney disease in Stockholm
An Electronic Triggering Decision-support System to Improve Detection, Management and Nephrologist Referral of Patients With Chronic Kidney Disease in Primary Care: A Pragmatic Cluster Randomized Controlled Trial
This study is testing a new electronic tool to help doctors in Stockholm find and treat chronic kidney disease better in their patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 780000 (estimated) |
| Sex | All |
| Sponsor | Karolinska Institutet Academic / other |
| Locations | 1 site (Stockholm) |
| Trial ID | NCT06386172 on ClinicalTrials.gov |
What this trial studies
This trial aims to enhance the identification and management of chronic kidney disease (CKD) among patients in Stockholm through an electronic clinical decision support (CDS) system. Conducted across 66 primary healthcare centers, the study will randomly assign these centers to either receive the CDS trigger or basic advice for 18 months. The CDS system is designed to assist general practitioners in following guideline-recommended processes for CKD care, addressing the significant under-detection and undertreatment of this condition. The trial will evaluate improvements in CKD care indicators among the participating centers.
Who should consider this trial
Good fit: Ideal candidates include adults with diabetes, hypertension, or existing chronic kidney disease, as well as those showing signs of kidney function decline.
Not a fit: Patients without any of the specified conditions or those who do not require annual kidney disease screening may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better identification and management of CKD, ultimately reducing healthcare costs and improving patient outcomes.
How similar studies have performed: Other studies utilizing clinical decision support systems have shown promise in improving patient care, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: People with conditions for which clinical guidelines recommend annual screening for kidney disease: * Diabetes * Hypertension * People with a chronic kidney disease diagnosis. * People with a rapidly declining eGFR (loss of 15% in the last 3 months or \> 5 ml/min/1.73m2 per year). * People with albuminuria (\>3 mg/mmol) Exclusion Criteria: * None
Where this trial is running
Stockholm
- Karolinska Institutet — Stockholm, Sweden (Recruiting)
Study contacts
- Principal investigator: Juan J Carrero, Prof — Karolinska Institutet
- Study coordinator: Juan J Carrero, Prof
- Email: juan.jesus.carrero@ki.se
- Phone: 0046739636948
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.